Alexion Pharmaceuticals Inc. Initiates Clinical Trial of Eculizumab as a Potential Treatment for Patients with STEC-HUS in Expanded Response to EHEC Crisis in Germany - BioSpace
Get #1 rated SkyGrid news app for free to follow all of your interests in real time
Sent from my iPad
No comments:
Post a Comment